The Oral Solid Dosage Contract Manufacturing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product Type (Tablets, Capsules, Powders, Granules, Others), By Mechanism (Immediate Release, Delayed Release, Controlled Release), By End-user (Large Size Companies, Medium & Small Size Companies, Others).
The Oral Solid Dosage Contract Manufacturing Market is projected to witness robust growth in 2024, fueled by the increasing demand for outsourced pharmaceutical manufacturing services, cost-effective drug development solutions, and flexible production capacities to meet the growing needs of the global pharmaceutical industry. Contract manufacturing organizations (CMOs) specializing in oral solid dosage forms, such as tablets, capsules, and powders, offer a wide range of services, including formulation development, process optimization, scale-up manufacturing, packaging, and regulatory support, to pharmaceutical companies seeking to outsource manufacturing operations and focus on core competencies.
Key drivers of the oral solid dosage contract manufacturing market include the rising complexity of drug formulations, stringent regulatory requirements, and the need for specialized expertise, infrastructure, and technologies to manufacture high-quality, safe, and effective pharmaceutical products in compliance with international quality standards and regulations. In addition, the increasing prevalence of chronic diseases, growing demand for generic drugs, and expanding pharmaceutical pipelines drive the outsourcing of manufacturing activities to CMOs, enabling pharmaceutical companies to expedite product development, reduce time-to-market, and optimize resource allocation.
Moreover, globalization, outsourcing trends, and strategic partnerships foster collaboration between pharmaceutical companies and CMOs, enabling access to global markets, geographical expansion, and risk mitigation strategies, such as capacity optimization, supply chain resilience, and cost savings. In addition, technological advancements in oral solid dosage manufacturing equipment, automation, and digitalization enhance production efficiency, quality control, and regulatory compliance, driving market growth and competitiveness.
A prominent trend in the oral solid dosage contract manufacturing market is the increasing outsourcing of manufacturing services by pharmaceutical companies. As pharmaceutical companies face challenges such as capacity constraints, cost pressures, and the need for flexibility in production, they are increasingly turning to contract manufacturers to meet their oral solid dosage manufacturing needs. Outsourcing allows pharmaceutical companies to leverage the expertise, infrastructure, and regulatory compliance of contract manufacturing organizations (CMOs) while focusing on core competencies such as research and development and marketing. This trend towards outsourcing oral solid dosage manufacturing is expected to continue as pharmaceutical companies seek to optimize their manufacturing operations and adapt to changing market dynamics.
A significant driver in the oral solid dosage contract manufacturing market is the growing demand for generic drugs and outsourced manufacturing services. With the expiration of patents on branded drugs and increasing pressure to reduce healthcare costs, there is growing demand for generic alternatives from both healthcare providers and patients. This demand for generic drugs, coupled with the need for cost-effective manufacturing solutions, drives pharmaceutical companies to outsource their oral solid dosage manufacturing to CMOs. Additionally, the increasing complexity of drug development and regulatory requirements further incentivizes pharmaceutical companies to partner with contract manufacturers with specialized expertise and capabilities in oral solid dosage manufacturing.
An exciting potential opportunity in the oral solid dosage contract manufacturing market lies in the expansion into emerging markets and specialized formulations. Emerging markets, particularly in Asia-Pacific and Latin America, offer significant growth opportunities due to their expanding pharmaceutical markets, favorable regulatory environments, and lower manufacturing costs. Contract manufacturers can capitalize on these opportunities by establishing manufacturing facilities or partnerships in emerging markets to serve local and international pharmaceutical companies. Furthermore, there is increasing demand for specialized formulations such as controlled-release, extended-release, and modified-release dosage forms, driven by the need for improved patient compliance and therapeutic efficacy. By offering expertise in specialized formulations, contract manufacturers can differentiate themselves in the market and capture opportunities in niche therapeutic areas, driving growth and innovation in oral solid dosage contract manufacturing.
By Product Type
By Mechanism
By End-user
Geographical Analysis
*List not exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Oral Solid Dosage Contract Manufacturing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Oral Solid Dosage Contract Manufacturing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
1. Executive Summary
1.1 Introduction to Oral Solid Dosage Contract Manufacturing Markets
1.2 Oral Solid Dosage Contract Manufacturing Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Oral Solid Dosage Contract Manufacturing Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Oral Solid Dosage Contract Manufacturing Market Trends
3.2 Key Oral Solid Dosage Contract Manufacturing Market Growth Drivers
3.3 Key Oral Solid Dosage Contract Manufacturing Market Growth Restraints
4 Oral Solid Dosage Contract Manufacturing Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Oral Solid Dosage Contract Manufacturing Market Segmentation- Outlook by Product
5.1 Tablets Market Outlook to 2030
5.2 Capsules Market Outlook to 2030
5.3 Powders Market Outlook to 2030
5.4 Granules Market Outlook to 2030
5.5 Others Market Outlook to 2030
6. Oral Solid Dosage Contract Manufacturing Market Segmentation- Outlook by Mechanism of Action
6.1 Immediate-release Market Outlook to 2030
6.2 Delayed-release Market Outlook to 2030
6.3 Controlled-release Market Outlook to 2030
7. Oral Solid Dosage Contract Manufacturing Market Segmentation- Outlook by End-Use
7.1 Large-size Companies Market Outlook to 2030
7.2 Medium- & Small-size Companies Market Outlook to 2030
7.3 Others Market Outlook to 2030
8. North America Oral Solid Dosage Contract Manufacturing Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Oral Solid Dosage Contract Manufacturing Market Growth Opportunities
8.3 North America Oral Solid Dosage Contract Manufacturing Market Outlook by Application
8.4 North America Oral Solid Dosage Contract Manufacturing Market Outlook by Type
8.5 North America Oral Solid Dosage Contract Manufacturing Market Outlook by Country
8.6 United States Oral Solid Dosage Contract Manufacturing Market Outlook
8.7 Canada Oral Solid Dosage Contract Manufacturing Market Outlook
8.8 Mexico Oral Solid Dosage Contract Manufacturing Market Outlook
9. Europe Oral Solid Dosage Contract Manufacturing Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Oral Solid Dosage Contract Manufacturing Market Outlook by Application
9.3 Europe Oral Solid Dosage Contract Manufacturing Market Outlook by Type
9.4 Europe Oral Solid Dosage Contract Manufacturing Market Outlook by Country
9.5 Germany Oral Solid Dosage Contract Manufacturing Market Outlook
9.6 France Oral Solid Dosage Contract Manufacturing Market Outlook
9.7 United Kingdom Oral Solid Dosage Contract Manufacturing Market Outlook
9.8 Spain Oral Solid Dosage Contract Manufacturing Market Outlook
9.9 Italy Oral Solid Dosage Contract Manufacturing Market Outlook
9.10 Other Europe Oral Solid Dosage Contract Manufacturing Market Outlook
10. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook by Application
10.3 Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook by Type
10.4 Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook by Country
10.5 China Oral Solid Dosage Contract Manufacturing Market Outlook
10.6 Japan Oral Solid Dosage Contract Manufacturing Market Outlook
10.7 India Oral Solid Dosage Contract Manufacturing Market Outlook
10.8 Other Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook
11. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Oral Solid Dosage Contract Manufacturing Market Outlook by Application
11.3 Latin America Oral Solid Dosage Contract Manufacturing Market Outlook by Type
11.4 Latin America Oral Solid Dosage Contract Manufacturing Market Outlook by Country
11.5 Brazil Oral Solid Dosage Contract Manufacturing Market Outlook
11.6 Argentina Oral Solid Dosage Contract Manufacturing Market Outlook
11.7 Other Latin America Oral Solid Dosage Contract Manufacturing Market Outlook
12. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaOral Solid Dosage Contract Manufacturing Market Outlook by Application
12.3 Middle East and AfricaOral Solid Dosage Contract Manufacturing Market Outlook by Type
12.4 Middle East and AfricaOral Solid Dosage Contract Manufacturing Market Outlook by Country
12.5 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Outlook
12.6 UAE Oral Solid Dosage Contract Manufacturing Market Outlook
12.7 South Africa Oral Solid Dosage Contract Manufacturing Market Outlook
12.8 Other Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Outlook
13 Profiles of major Oral Solid Dosage Contract Manufacturing Companies
Catalent Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Lonza Group
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Piramal Pharma Solutions
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Aenova Group
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Jubilant Biosys Limited
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Boehringer Ingelheim GmbH
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Abbvie Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Patheon
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Recipharm AB
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Next Pharma AB
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Siegfried Holding AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Corden Pharma International
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
By Product Type
By Mechanism
By End-user
Geographical Analysis